S. Hashimoto

发表

β‐Hydroxyisovalerylshikonin Is a Novel and Potent Inhibitor of Protein Tyrosine Kinases

M. Shibuya, Ying Xu, Y. Uehara, 2002, Japanese journal of cancer research : Gann.

Topoisomerase inhibitors potentiate the effect of retinoic acid on cell growth inhibition and induction of differentiation of leukemia HL-60 cells.

S. Hashimoto, S. Nakajo, K. Nakaya, 1994, Leukemia research.

Bufalin reduces the level of topoisomerase II in human leukemia cells and affects the cytotoxicity of anticancer drugs.

T. Yoshida, S. Hashimoto, Y. Masuda, 1997, Leukemia research.

Potentiation of tumoricidal properties of murine macrophages by Nocardia rubra cell wall skeleton (N-CWS).

K. Nakahara, Y. Horii, S. Hashimoto, 1984, The Journal of antibiotics.

The mechanism of geranylgeraniol-induced apoptosis involves activation, by a caspase-3-like protease, of a c-jun N-terminal kinase signaling cascade and differs from mechanisms of apoptosis induced by conventional chemotherapeutic drugs.

S. Hashimoto, Y. Masuda, T. Aiuchi, 2000, Leukemia research.

Biological and immunological properties of human hepatocyte growth factor from plasma of patients with fulminant hepatic failure.

H. Tsubouchi, E. Gohda, S. Hashimoto, 1990, Biochimica et biophysica acta.

Selective Inhibitory Effect of Bufalin on Growth of Human Tumor Cells in vitro: Association with the Induction of Apoptosis in Leukemia HL‐60 Cells

Takemi Yoshida, S. Hashimoto, Y. Masuda, 1994, Japanese journal of cancer research : Gann.

Antitumor effects of novel immunoactive peptides, FK-156 and its synthetic derivatives.

K. Nakahara, M. Okuhara, H. Imanaka, 1983, The Journal of antibiotics.

Regulatory effects of noradrenaline on the production of Th1 and Th2 cytokines by cultured spleen cells in SAMP1 mice

S. Hashimoto, T. Hosokawa, R. Naruse, 2004 .

Cell cycle arrest and protein kinase modulating effect of bufalin on human leukemia ML1 cells.

M. Watabe, S. Hashimoto, S. Nakajo, 1994, Anticancer research.

Immune deficiency of cataract Shionogi (CTS) mouse. II. Impaired in vivo T cell-mediated immune response.

S. Hashimoto, A. Arimura, M. Nagata, 1990, Immunological investigations.

Vitamin K2 induces apoptosis of a novel cell line established from a patient with myelodysplastic syndrome in blastic transformation

M. Yaguchi, K. Ohyashiki, S. Hashimoto, 1999, Leukemia.

Novel role of vitamin K2: a potent inducer of differentiation of various human myeloid leukemia cell lines.

S. Hashimoto, S. Nakajo, K. Nakaya, 1994, Biochemical and biophysical research communications.

beta-hydroxyisovalerylshikonin inhibits the cell growth of various cancer cell lines and induces apoptosis in leukemia HL-60 cells through a mechanism different from those of Fas and etoposide.

S. Hashimoto, Y. Masuda, T. Aiuchi, 1999, Journal of biochemistry.

Induction of apoptosis in various tumor cell lines by geranylgeraniol.

S. Hashimoto, Y. Masuda, T. Aiuchi, 1997, Anticancer research.